Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06519487 · ClinicalTrials.gov registry record · NA
Social Experiences and Demographic Factors in the Regulation of Immune Cells
A NA study of Inflammatory Response and RNA, sponsored by Morgan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 2
- Study locations
NCT06519487 is a NA study of Inflammatory Response and RNA that is actively recruiting participants, run by Morgan State University. The registered enrollment target is 480 participants, above the 148-participant average among 16 other Inflammatory Response trials with a reported enrollment target (224% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06519487, a NA study of Inflammatory Response and RNA, is actively recruiting participants, sponsored by Morgan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 2
- Study locations
Study Summary
Immune-mediated inflammatory diseases are a health burden for approximately seven percent of the population of Western nations. Preliminary data suggest variations in ethnic identity and/or geography influence discrimination experiences and inflammatory response trends. This study investigates how geography, ethnicity, and laboratory manipulation of discrimination experiences affect immune cell function and genomic regulation. Flow cytometry and immune cell stimulation will test monocytes collected from peripheral blood for functional effects. Next-generation transcriptomics and epigenomics will assess genomic and epigenetic mechanisms. The hypothesis is that geography, self-identified race, and ethnicity, interacting with laboratory discrimination conditions during the virtual ballgame Cyberball™, significantly affect immune cell function through genomic and epigenetic mechanisms, with perceived discrimination as a moderating factor on the immune outcomes. The transdisciplinary nature of the proposed study aims to provide valuable insights into differential susceptibility to immune-mediated inflammatory diseases across diverse populations. Uncovering these insights will better inform population-relevant interventions for immune-mediated inflammatory diseases.
Conditions Studied
Interventions
- BEHAVIORAL Cyberball
Study Locations (2)
Maryland
- Morgan State University - Baltimore
Texas
- Texas Christian University - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06519487
The ClinicalTrials.gov registry entry for NCT06519487 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 148-participant average among 16 other Inflammatory Response trials with a reported enrollment target (224% higher). The listed sponsor is Morgan State University, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Inflammatory Response appearing as the primary indexed condition, and to 1 intervention - of which Cyberball is the first listed.
NCT06519487 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT06519487 about?
NCT06519487 is a clinical study titled "Social Experiences and Demographic Factors in the Regulation of Immune Cells". Immune-mediated inflammatory diseases are a health burden for approximately seven percent of the population of Western nations. Preliminary data suggest variations in ethnic identity and/or geography influence discrimination experiences and inflammatory response trends. This study investigates how g...
What is the current status of trial NCT06519487?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2025-02-03. Estimated completion is 2029-02-28.
What conditions does trial NCT06519487 study?
This clinical trial studies the following conditions: Inflammatory Response, RNA, Perceived Discrimination.
What interventions are being tested in trial NCT06519487?
The interventions under investigation include: Cyberball (BEHAVIORAL).
Who is sponsoring clinical trial NCT06519487?
This trial is sponsored by Morgan State University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06519487 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
RECRUITING · NA
-
Association Between Body Composition and Pain in Spinal Cord Injury
RECRUITING · NA
-
Daoist Zhanzhuang and Human Flourishing
RECRUITING · NA
-
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
ACTIVE NOT RECRUITING · NA
-
Beef and Plant Burger Metabolomics Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.